2020 Annual Meeting | C102 - Peripheral Neuropathy 2: Approach to Sensory Neuropathies and Neuropathies Associated with Rheumatologic and Hematologic Disorders

Date Monday 04/27/20

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Michelle L. Mauermann, MD, F�鶹��ýӳ��

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to identify the causes of large and small fiber sensory neuropathies; perform appropriate testing for evaluation of sensory neuropathies; and determine a rational approach to treating sensory neuropathies. Participants should be able to recognize the clinical presentation of vasculitic neuropathies, establish diagnosis and work-up of vasculitic neuropathies and determine the evidence-based treatment for vasculitic neuropathies. Participants should become familiar with the relevance of monoclonal gammopathies in relationship to peripheral neuropathy; perform appropriate testing for plasmacytic disorders; and determine treatment approach to paraproteinemic disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:05 PM	Introduction	Introduction Michelle L. Mauermann, MD, F�鶹��ýӳ��
01:05 PM - 01:40 PM	Speaker	Sensory Neuropathies Sarah E. Berini, MD
01:40 PM - 02:15 PM	Speaker	Vasculitic Neuropathies Chafic Y. Karam, MD
02:15 PM - 02:50 PM	Speaker	Paraproteinemic Neuropathies Michelle L. Mauermann, MD, F�鶹��ýӳ��
02:50 PM - 03:00 PM	Q&A	Discussion/Questions and Answers

Faculty Disclosures
Michelle L. Mauermann, MD, F�鶹��ýӳ��	The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
Sarah E. Berini, MD	Dr. Berini has nothing to disclose.